IMPLANET is an international company founded by European institutional and private investors, with headquarters near Bordeaux (FR) and a US subsidiary in Boston.
Implanet's focus is on products for the spine, knee and arthroscopy.
Implanet's flagship product, the latest generation Jazz™ implant, is designed to improve the treatment of spinal conditions requiring surgical spinal fusion. Jazz™ is protected by four groups of international patents and has 510(k) clearance from the U.S. Food and Drug Administration (FDA) as well as a CE mark.
Technopole Bordeaux Montesquieu Allée François Magendie, 33650 Martillac – France
|Trading entity / Person
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.